Navigation Links
Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles 'Snuffy' Myers Announces Vitamin D Clinical Trials
Date:4/16/2008

CHARLOTTESVILLE, Va., April 16 /PRNewswire-USNewswire/ -- The Foundation for Cancer Research and Education (FCRE) announced today that prostate cancer oncologist and survivor, Dr. Charles "Snuffy" Myers, will lecture on new treatments for prostate cancer at Westminster at Lake Ridge, VA on April 26, 2008 from 9:30 AM--12:30 PM.

"With the recent press around prostate cancer vaccines, people are very excited about new treatments," Myers says. "The good news is there are many things people can do to prevent recurrence before it starts."

Some of those treatments include:

-- Celebrex

-- Proscar/Avodart

-- Leukine

-- Calcitriol

-- Avastin

-- Mediterranean heart healthy diet

-- Vitamin D3

-- Pomegranate.

In addition, to his lecture, Dr Myers will also be announcing his new clinical trials meant to investigate one of the most promising of those treatments -- vitamin D3.

"The current research and what I see in my patients suggests that vitamin D can dramatically slow the PSA doubling times that indicate recurrent and often lethal disease," Myers says. "The trials are meant to show Vitamin D3's role in slowing or stopping the growth of prostate cancer that has recurred after surgery or radiation in a much more substantive way." Information about the trial and how to participate will be provided at the meeting.

The program, located at Westminster at Lake Ridge, 12191 Clipper Drive, Lake Ridge or Woodbridge, VA, is free of charge and includes a heart-healthy buffet breakfast for all attendees. Sponsors include FCRE, The Virginia Prostate Cancer Coalition, Us TOO, Westminster at Lake Ridge, and Potomac Hospital.

This will be the fourth time Myers has presented at Lake Ridge but the first time he publicly announces the foundation's new research efforts.

"Myers's always provides informative lectures," notes Richard Gillespie, head of the Lake Ridge Us TOO Chapter. "But we're eager to hear about the new trials Dr. Myers is working on."

For information on the event or directions please call Richard Gillespie at 703-497-0628.

About FCRE

The Foundation for Cancer Research and Education (FCRE) is dedicated to cutting edge research and clinically driven educational programs. A streamlined organization with specific research goals, FCRE's mission is to prolong patients' lives with focused research strategies. For more information or for a list of FCRE's outreach programs call 800-305-2432 or go to http://www.cancer-foundation.org.


'/>"/>
SOURCE Foundation for Cancer Research and Education
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
2. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
3. Gene Fusion Subtypes in Prostate Carcinoma Have Clinical Implications
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
6. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
7. Study Suggests Soy Protein May Reduce Prostate Cancer Risk
8. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
9. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
10. Prostate Cancer Treatment Centre Receives Funding for Clinical Trials
11. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... Oct. 4, 2017 OBP Medical ... illuminating medical devices, today announced regulatory approval from ... Agency (or Agência Nacional de Vigilância Sanitária (ANVISA)) ... cordless surgical retractor with integrated LED light source ... illumination and exposure of a tissue pocket or ...
(Date:10/2/2017)... Halo Labs announces the European launch of their new low volume, ... 2017 in Cambridge, U.K on October 4th. ... samples with unprecedented speed and sensitivity while using far less sample ... ... system ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... PurhealthRX ... CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will ... and providing a CBD form that can be easily incorporated into liquid products, while ...
(Date:10/13/2017)... QUEENS, N.Y (PRWEB) , ... October 13, 2017 , ... ... recently became a member of ElderCounsel, a national organization of elder law and special ... constantly changing laws and rules. It also provides a forum to network with elder ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers care ... have a waiver for care if the client has a cognitive impairment diagnosis. ... for care, is often waived, so the benefits from their insurance start immediately,” said ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
Breaking Medicine News(10 mins):